Search Results - "Manjelievskaia, J"
-
1
-
2
TP3 CHARACTERIZING AND COMPARING US COMMERCIALLY-INSURED PATIENTS WITH OPIOID USE DISORDER (OUD) BY RECEIPT OF MEDICATION-ASSISTED TREATMENT (MAT)
Published in Value in health (01-11-2019)Get full text
Journal Article -
3
-
4
PMH68 IMPLEMENTING AND INTERPRETING A PROPOSED NEW MEASURE FOR HEDIS® 2020: PHARMACOTHERAPY FOR OPIOID USE DISORDER (OUD)
Published in Value in health (01-11-2019)Get full text
Journal Article -
5
CO10 Early Adoption and Utilization of Perfluorohexyloctane for Treatment of Dry Eye Disease
Published in Value in health (01-06-2024)Get full text
Journal Article -
6
ADHERENCE AND PERSISTENCE AMONG HEREDITARY ANGIOEDEMA PATIENTS TREATED WITH BEROTRALSTAT, LANADELUMAB, AND SUBCUTANEOUS PLASMA-DERIVED C1-INHIBITOR
Published in Annals of allergy, asthma, & immunology (01-11-2024)“…Berotralstat is a novel, targeted oral long-term prophylactic (LTP) treatment for hereditary angioedema (HAE). Real-world evidence comparing WAO/EAACI…”
Get full text
Journal Article -
7
EE204 All-Cause Healthcare Costs By Race Among Medicaid-Insured Males with Duchenne Muscular Dystrophy Using U.S. Real-World Data
Published in Value in health (01-06-2023)Get full text
Journal Article -
8
CO135 Clinical and Economic Outcomes Associated with Transitions of Tobacco Use Among a Cohort of Adult Male Smokers Using U.S. Real-World Data
Published in Value in health (01-06-2023)Get full text
Journal Article -
9
-
10
P219 SEASONALITY OF ASTHMA EXACERBATIONS IN PATIENTS TREATED WITH MEPOLIZUMAB
Published in Annals of allergy, asthma, & immunology (01-11-2019)Get full text
Journal Article -
11
P203 REAL WORLD IMPACT OF MEPOLIZUMAB ON EXACERBATION REDUCTION AND ASSOCIATED COST IN PATIENTS WITH ASTHMA
Published in Annals of allergy, asthma, & immunology (01-11-2019)Get full text
Journal Article -
12
-
13
PMU40 VALIDATION OF AN ICD-10 CODING ADAPTATION FOR THE CHARLSON COMORBIDITY INDEX IN UNITED STATES HEALTHCARE ADMINISTRATIVE DATA
Published in Value in health (01-05-2020)Get full text
Journal Article -
14
PRS51 THREE METHODS FOR DEFINING ASTHMA EXACERBATIONS IN REAL-WORLD DATA
Published in Value in health (01-05-2019)Get full text
Journal Article -
15
Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study
Published in Patient preference and adherence (01-01-2022)“…Most conventional, oral, preventive treatments for migraine are non-specific and ~50% of patients discontinue them within six months. In 2018, the Food and…”
Get full text
Journal Article -
16
-
17
PCN7 - Impact of Skeletal-Related Events on Anti-Tumor Therapy Pattern in Patients with Bone Metastases from Prostate Cancer
Published in Value in health (01-05-2018)Get full text
Journal Article -
18
-
19
Impact of Skeletal-Related Events on Anti-Tumor Therapy Pattern in Patients with Bone Metastases from Prostate Cancer
Published in Value in health (01-05-2018)Get full text
Journal Article -
20
Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs
Published in Journal of asthma and allergy (01-01-2020)“…Results from clinical trials in patients with severe eosinophilic asthma have demonstrated that mepolizumab is well tolerated and is associated with improved…”
Get full text
Journal Article